18:27 , Nov 30, 2018 |  BC Week In Review  |  Company News

WuXi NextCode investing in genomic sequencing project in Ireland

WuXi NextCode Genomics Inc. (Cambridge, Mass.) unveiled plans to expand an Irish sequencing program by investing up to $400 million in its partner Genomics Medicine Ireland Ltd. (Dublin, Ireland), which it acquired in November. The...
23:49 , Nov 27, 2018 |  BC Extra  |  Company News

WuXi NextCode investing in genomic sequencing project in Ireland

WuXi NextCode Genomics Inc. (Cambridge, Mass.) unveiled plans to expand an Irish sequencing program by investing up to $400 million in its recently acquired partner, Genomics Medicine Ireland Ltd. (Dublin, Ireland). The investment aims to...
08:00 , Nov 19, 2012 |  BioCentury  |  Regulation

Antibiotics reset

There is a consensus among the U.S. government, industry and the medical community that the failure of antibiotic development to keep pace with the evolution of bacterial pathogens constitutes a public health crisis, and that...
07:00 , May 16, 2011 |  BC Week In Review  |  Company News

Advanced Life infectious news

Advanced Life Sciences said it suspended operations and terminated its staff due to a lack of cash. In January, the company said it would explore strategic alternatives, including an acquisition or partnership. The January decision...
07:00 , Mar 28, 2011 |  BC Week In Review  |  Financial News

Advanced Life financial update

Advanced Life Sciences plans to implement a 1-for-30 reverse stock split, effective March 28. Prior to the split, the company has 323.6 million shares outstanding. Advanced Life Sciences Holdings Inc. (OTCBB:ADLS), Woodridge, Ill.   Business:...
08:00 , Mar 3, 2011 |  BC Innovations  |  Strategy

Scots aggregate a ligase platform

For the past three years, Scottish Enterprise has been working with multiple international academic and commercial labs to investigate therapeutic targets that were regarded as too challenging by many drug development companies. Now, the Scottish...
08:00 , Jan 10, 2011 |  BC Week In Review  |  Company News

Advanced Life infectious news

Advanced Life will explore strategic alternatives, including an acquisition or partnership. The decision was based on the company's assessment of the financial resources required to conduct a registration program for its lead compound, Restanza cethromycin....
08:00 , Nov 15, 2010 |  BC Week In Review  |  Company News

Advanced Life, Abbott, Pfizer infectious news

Advanced Life said it submitted a proposal to NIH's National Institute of Allergy and Infectious Diseases (NIAID) to develop an IV formulation of Restanza cethromycin. The proposal requests $38 million over five years for: preclinical...
07:00 , Oct 4, 2010 |  BC Week In Review  |  Financial News

Advanced Life completes warrant exercise

Advanced Life Sciences Holdings Inc. (OTCBB:ADLS), Woodridge, Ill.   Business: Infectious, Cancer, Pulmonary   Date completed: 9/28/10   Type: Warrant exercise   Raised: $1.5 million   Shares: 361,968   Price: $4.20   Shares after offering:...
07:00 , Sep 6, 2010 |  BioCentury  |  Strategy

Laying siege

sanofi-aventis Group made clear in its conference call last week that it's in no hurry to complete its proposed acquisition of Genzyme Corp. - with the obvious implication that time is on its side. If...